Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Glenmark Pharmaceuticals Ltd is up for a fifth straight session today. The stock is quoting at Rs 1979, up 0.2% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.14% on the day, quoting at 26010.15. The Sensex is at 85166.94, down 0.12%. Glenmark Pharmaceuticals Ltd has gained around 5.89% in last one month.
Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has gained around 0.68% in last one month and is currently quoting at 22808.7, down 0.42% on the day. The volume in the stock stood at 1.52 lakh shares today, compared to the daily average of 11.36 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 1982.6, down 0.03% on the day. Glenmark Pharmaceuticals Ltd is up 27.57% in last one year as compared to a 5.44% jump in NIFTY and a 2.05% jump in the Nifty Pharma index.
The PE of the stock is 37.86 based on TTM earnings ending September 25.
Citing IQVIA sales data for the 12 months ending October 2025, the company said the U.S. market for Leucovorin Calcium for Injection, 350 mg/vial recorded annual sales of approximately $16.8 million, including the brand product and all available therapeutic equivalents.
Glenmark emphasized that its Leucovorin Calcium for Injection USP, 350 mg/vial is approved only for the indications listed on its FDA-approved label and is not marketed for all RLD indications.
Marc Kikuchi, President & Business Head, North America said, “We are pleased to announce the upcoming launch of Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial, further expanding our portfolio of products within the institutional channel, while also strengthening our commitment to bring to market quality and affordable alternatives for patients.”
Glenmark Pharmaceuticals is engaged in the business of development, manufacturing, and marketing of pharmaceutical products, both formulations and active pharmaceutical ingredients, to regulated and semi-regulated markets.
Glenmark Pharmaceuticals, the company, reported a 72.3% jump in consolidated net profit to Rs 610.25 crore on a 76.6% increase in revenue from operations to Rs 6,003.79 crore in Q2 FY25.
The counter rose 0.24% to Rs 1,957.60 on the BSE.
The counter rose 0.01% to Rs 1,947.35 on the BSE.
PSU bank shares fell after advancing in the past two trading sessions.
At 12:25 IST, the barometer index, the S&P BSE Sensex jumped 145.72 points or 0.17% to 85,755.23. The Nifty 50 index surged 18.95 points or 0.08% to 26,224.85.
The Nifty 50 and the Sensex hit fresh all-time highs in morning trade at 26,306.95 and 86,026.18, respectively, while the Bank Nifty also scaled a new record high of 59,804.65.
In the broader market, the S&P BSE Mid-Cap index shed 0.21% and the S&P BSE Small-Cap index fell 0.28%.
The market breadth was almost even. On the BSE,1,960 shares rose and 1,950 shares fell. A total of 219 shares were unchanged.
Derivatives:
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, added 1.37% to 12.13. The Nifty 30 December 2025 futures were trading at 26,403.10, at a premium of 178.25 points as compared with the spot at 26,224.85.
The Nifty option chain for the 30 December 2025 expiry showed a maximum call OI of 62.4 lakh contracts at the 26,000 strike price. Maximum put OI of 77 lakh contracts was seen at 26,000 strike price.
Buzzing Index:
The Nifty PSU Bank index declined 0.92% to 8,473.05. The index rose 2.23% in the past two consecutive trading sessions.
Indian Bank (down 3.06%), Bank of India (down 1.83%), Union Bank of India (down 1.35%), Indian Overseas Bank (down 1.04%), State Bank of India (down 0.9%), Punjab & Sind Bank (down 0.76%), Punjab National Bank (down 0.64%), UCO Bank (down 0.61%), Bank of Baroda (down 0.57%) and Bank of Maharashtra (down 0.57%) declined.
Stocks in Spotlight:
Lokesh Machines fell 1.96% after the company announced that it received an order worth Rs 7.96 crore from Kirloskar Oil Engines.
Glenmark Pharmaceuticals rose 0.68%. The U.S. FDA issued a positive establishment inspection report (EIR) with voluntary action indicated (VAI) status for the company's formulations manufacturing facility in Monroe, North Carolina.
The inspection at the Monroe facility was conducted from 9 June to 17 June 2025. Glenmark said that with this positive development, it will restart commercial manufacturing at the facility.
Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 1941, up 1.03% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.18% on the day, quoting at 26251.5. The Sensex is at 85859.63, up 0.29%. Glenmark Pharmaceuticals Ltd has gained around 6.94% in last one month.
Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has gained around 2.75% in last one month and is currently quoting at 22862.35, down 0% on the day. The volume in the stock stood at 9.89 lakh shares today, compared to the daily average of 12.05 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 1952, up 0.86% on the day. Glenmark Pharmaceuticals Ltd is up 29.82% in last one year as compared to a 9.77% jump in NIFTY and a 5.22% jump in the Nifty Pharma index.
The PE of the stock is 36.84 based on TTM earnings ending September 25.
Glenmark Pharmaceuticals announced the launch of Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, the world's first nebulized, fixed-dose triple therapy for the treatment of Chronic Obstructive Pulmonary Disease (COPD).
Both products combine three proven medicines - Glycopyrronium, Formoterol, and Budesonide - to reduce airway obstruction, inflammation, and improve lung function and symptom control. As a single, easy-to-use nebulized therapy, it minimizes the burden of multiple medications. This marks a breakthrough as a new standard of care for COPD patients, especially those who struggle with using Metered Dose Inhalers (MDI) or Dry Powder Inhalers (DPI).